Severe acute respiratory syndrome (SARS) is a life-threatening form of atypical pneumonia caused by infection with a novel human coronavirus (SARS-CoV). It rapidly spreaded from southern China to several other countries during late 2002 and early 2003.
In our preceding paper, we have reported that cinanserin (1), a well-characterized serotonin antagonist, is a good potential lead compound for designing more active inhibitors of 3CL protease. 12) Herein we report the design and synthesis of two series of cinanserin derivatives as novel inhibitors of SARS-CoV 3CL protease.
According to the 3D model of the cinanserin-3CL protease complex, 12) three series of cinanserin analogs have been designed and synthesized respectively (Table 1) . In order to modify the cinnamide moiety of cinanserin, compounds 2-9 were synthesized in which cinnamoyl group is replaced with other phenyl-containing groups. Compounds 10-22 and 26, 27 were designed and prepared to diversify the substitute groups and chains on sulfur atom of cinanserin. Compounds 23-25 were prepared to vary the thioether group of cinanserin into ether and sulfoxide respectively.
Chemical Synthesis Compounds 2-22 were synthesized via a three-step route (Chart 1). 13, 14) The starting material 2-aminothiophenol (28) was first treated with excessive sodium isopropoxide at room temperature to form sodium salt, which was then reacted with a variety of alkyl halides or aminoalkyl halides, yielding intermediates 29-42. Most of the intermediates are known except 35, 36, 37 and 42. Acylation of the intermediates with the corresponding acyl chloride produced the target compounds 2-22 (Chart 1). Similarly, compounds 23 and 24 were obtained from 2-aminophenol (43) and 2-amino-4-nitrophenol (44) via the same approach respectively (Chart 2).
Sulfoxide 25 was prepared by oxidation of cinanserin (1) with sodium periodate in acetonitrile. The synthesis of compounds 26 and 27 also started from 2-aminothiophenol (28), which was reacted with an excess of cinnamoyl chloride (47, RϭH) or 2-cyanocinnamoyl chloride (48, RϭCN) in the presence of triethylamine at reflux in dichloromethane to give the desired products 29 and 30 respectively (Chart 3). Among the target compounds, 2, 4, 5, 11, 21, 23 and 24 are known, but their 1 H-NMR data have not been reported yet.
Biological Results and SAR Discussion
The bioactivities of compounds 2-27 were measured by a fluorescence resonance energy transfer (FRET)-based assay using 5-(2-aminoethylamino)naphthelenesulfonic acid (Edans) and 4-(4-dimethylaminophenylazo)benzoic acid (Dabcyl) as the energy transfer pair. The peptide substrate is Dabcyl-KN-STLQSGLRKE-Edans labeled with Edans and Dabcyl. The inhibition of SARS-CoV 3CL protease slowly increased in the concentration range from 0 to 500 mM of the corresponding compounds. The IC 50 value of the compounds in inhibiting the catalytic activity of SARS-CoV 3CL protease was calculated by fitting the dose-response curve using a logistic derivative equation.
12) The results are summarized in Table 1 .
Of the synthetic derivatives tested, compounds 7, 10, 13, 26 and 27 displayed remarkable inhibitory activity of SARSCoV 3CL protease, indicating that the cinnamoyl group is crucial for good inhibition of SARS-CoV 3CL protease. Compound 7 is about 2-fold more potent than cinanserin, suggesting that introduction of a cyano substituent on a-position of cinnamoyl group increased the inhibitory activity. Replacement of the dimethylamino group of cinanserin with electron-withdrawing group such as an ester group (13) or elimination of the dimethylamino group (allylthioether 10) enhanced remarkably the inhibitory activity, and the chain length of the thioether is not critical of the inhibitory activity (compound 11 vs. 12; 15 vs. 16). When the phenylthioether moiety in cinanserin was changed to phenylether group (23) or oxidized to sulfoxide (25) , no inhibitory activity was observed. Unexpectedly, replacement of the 3-dimethylaminopropyl group in cinanserin with an additional cinnamoyl group, giving compound 26 which showed very potent inhibition against 3CL protease, and is 300-fold more potent than cinanserin itself. These observations are in good coincidence with the molecular docking study of the complex of 3Cl protease with the ligand. Docking Study The 3D structure of compound 26 was constructed by the Corina online service (http://www.molnet.com/online_demos/corina_demo.html). The 3D model of SARS-CoV 3CL protease was retrieved from the Brookhaven Protein Data Bank (PDB) (http://www.rcsb.org/pdb/) (PDB ID: 1UJ1, Chain A).
12) AutoDock Tools (http://autodock.
scripps.edu/resources/adt) were used to add polar hydrogen and assign partial charges to both protein and ligand. AutoDock 3.0 15) was employed for the docking of compound 26 to SARS-3CL protease. All the molecular modeling and docking simulations were performed on a Silicon Graphics Origin 3800 (with 128 CPUs).
To address the SARS-CoV 3CL protease inhibitory activity of compound 26, we applied molecular docking to identify the possible binding mode between the compound and the enzyme. The top pose, ranked by the "estimated free energy of binding", was chosen as the predicted binding mode. For the top pose, as shown in Fig. 1, compound 26 locates deep inside the S1 pocket 12) with appropriate steric complement. Fourty hydrophobic interaction atom pairs between the compound and the enzyme were detected by using the LIG-PLOT. 16) In the light of this binding mode, compound 26 occupies the substrate binding subsite, indicating that it is a competitive ligand for the enzyme's substrate, and the predicted dissociation constant K D is 0.35 M. Compared with the binding mode of cinanserin and SARS-CoV 3CL protease, 12) compound 26 binds tighter with the protease than cinanserin. This might lead to the stronger inhibitory activity against the protease.
Conclusion
Three series of cinanserin analogs derived from the modification of cinnamenyl, phenylthioether group and sulfurcontaining chain of cinanserin have been designed and synthesized as potential inhibitors of SARS-CoV 3CL protease. The inhibitory activities of these compounds were assessed by FRET assay. Some analogs showed improved inhibitory activities against SARS-CoV 3CL protease compared with cinanserin itself. The IC 50 values of compounds 10, 13, 26 and 27 are lower than 100 mM. Among them compound 26 is the most potent one . It is much more potent than cinanserin by two orders of magnitude in the inhibition of SARS 3CL protease.
Experimental
General All starting materials were commercially available and used without further purification. All water-sensitive reactions were carried out in oven-dried glassware with a stirring bar under a nitrogen atmosphere. Toluene was dried over sodium, chloroform and dichloromethane were dried over CaH 2 . Melting points were measured in capillary tube on a Buchi 510 melting point apparatus without correction. IR spectra were recorded on a Nicolet Magna IR750 spectrometer with KBr disks or film. NMR spectra were recorded on Brucker AMX-400 (400 MHz). Chemical shifts were reported in parts per million (ppm, d units) downfield from chloroform where solvent peak was used as internal standard. Proton coupling patterns were described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br). Low-and high-resolution mass spectra (LR-MS and HR-MS) were given with electric ionization (EI) produced by Varian MAT-711 and Finnigan MAT-95 instrument.
2-(3-Methoxypropylthio)benzenamine (35)
To a solution of sodium isopropoxide prepared from sodium (0.35 g, 15.2 mmol) in isopropanol (20 ml) was added 28 (1.7 ml, 15 mmol), and the mixture was stirred at room temperature for 30 min. 1-Chloro-3-methoxypropane (1.63 g, 15 mmol) was then added to. The reaction mixture was stirred at reflux for 4 h, and con-Vol. 56, No. 10 densed in vaccum. The residue was treated with water and extracted with ether twice. The combined organic layer was washed with water and dried over anhydrous MgSO 4 . After removal of the solvent, the residue was purified by flash column chromatography on silica gel eluting with petroether (80) : chloroform (13) 13) To a solution of 29 (210 mg, 1.0 mmol) in CHCl 3 (2 ml) was added 3-phenylpropionyl chloride (168 mg, 1.0 mmol) in CHCl 3 (3 ml) dropwise. After refluxing for 1 h, the reaction mixture was alkalized with ammonia solution (25%). The organic layer was dried over anhydrous MgSO 4 and concentrated in vacuum. The residue was purified by flash column chromatography on silica gel eluting with a mixture of chloroform (9) 13) In the same manner as described for 2, it was prepared from 29 and benzoyl chloride in a yield of 95% as a brown gel. IR (KBr) N-[2-(3-Dimethylaminopropylthio)phenyl]-2-cyanocinnamide (7) In the same manner as described for 2, it was prepared from 29 and 2-cyanocinnamoyl chloride in a yield of 64% as an orange solid recrystallized from ethyl acetate-n-hexane, mp 85-86°C. 19) In the same manner as described for 2, it was prepared from 31 20) and cinnamoyl chloride in a yield of 63% as a white crystal recrystallized from ethyl acetate-n-hexane, mp 138 N-(2-Carbomethoxyethylthiophenyl)cinnamide (13) In the same manner as described for 2, it was prepared from 33 22) and cinnamoyl chloride in a yield of 84% as a yellow solid recrystallized from ethyl acetate-n-hexane, mp 106-107°C. IR (Film) In the same manner as described for 2, it was prepared from 38 24) and cinnamoyl chloride in a yield of 96% as a brownish oil. IR (KBr) cm 26) In the same manner as described for 2, it was prepared from 41 26) and cinnamoyl chloride in a yield of 81% as a yellowish oil. IR (KBr) cm 13) In the same manner as described for 2, it was prepared from 45 13) and cinnamoyl chloride in a yield of 58% as a brownish oil. IR 26) In the same manner as described for 2, it was prepared from 46 26) and cinnamoyl chloride in a yield of 58% as a brownish oil, mp 124. To a solution of 1 (340 mg, 1.0 mmol) in CH 3 CN (2.5 ml) was added aqueous NaIO 4 (0.5 M, 2.5 ml) dropwise at Ϫ10°C. After stirring at 0°C for 12 h, an additional aqueous NaIO 4 (0.5 M, 2.5 ml) was added to the mixture, the stirring was continued for 20 h. The mixture was filtered, and extracted with CHCl 3 . The combined organic layer was washed, and dried over anhydrous N-(2-Cinnamoylthiophenyl)cinnamide (26) To a solution of 28 (125 mg, 1.0 mmol) and Et 3 N (0.6 ml) in CH 2 Cl 2 (5 ml) was added at room temperature a solution of cinnamoyl chloride (340 mg, 2.0 mmol) in CH 2 Cl 2 (10 ml). After refluxing for 1 h, the reaction mixture was washed with water and the organic layer was dried over anhydrous MgSO 4 . The solvent was removed in vacuum and the residue was purified by flash column chromatography on silica gel eluting with a mixture of petroleum ether (85) : chloroform (10) : ethyl acetate (5) 
